Clinical Trial Update: The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial from Alexandria University evaluating whether nanosilver fluoride desensitises teeth affected by Molar Incisor Hypomi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity
• Molar-incisor Hypomineralization

Drugs mentioned

• Nanosilver Fluoride (nanosilver fluoride)

Snippet

Sponsor: Alexandria University | Conditions: Molar Incisor Hypomineralization, Hypersensitivity | Phase 2, Phase 3 | Status: COMPLETED